Kimberly Stephens
About Kimberly Stephens
Kimberly Stephens serves as the Mid West Business Director at Magnolia Medical Technologies, where she has worked since 2019. With a background in commercial development and diagnostic management, she has played a significant role in promoting Steripath and advancing sepsis testing standards.
Current Role at Magnolia Medical Technologies
Kimberly Stephens serves as the Mid West Business Director at Magnolia Medical Technologies since 2019. In this role, she focuses on the clinical adoption of Steripath, a product that has undergone extensive evaluation in clinical studies. Her efforts have been instrumental in promoting the use of Steripath across various healthcare settings, including academic institutions and military medical centers.
Previous Experience at Accelerate Diagnostics
Prior to her current position, Kimberly worked at Accelerate Diagnostics as the Commercial Development Director from 2016 to 2019. During her tenure, she was involved in the promotion of Steripath, contributing to its evaluation in 14 clinical studies and its presence in five peer-reviewed publications. Her work focused on establishing the product's credibility in the market.
Career Background in Diagnostics and Sales
Kimberly has a diverse background in the diagnostics and healthcare industry. She held the position of Diagnostic Business Manager at Luminex Corporation for nine months in 2015-2016. Earlier in her career, she worked as a Professional Sales Representative at Johnson & Johnson for nine years and as a Skin Care Specialist at Merck for two years. Additionally, she served as a Strategic Account Manager at Ventana Medical Systems from 2007 to 2015.
Educational Background
Kimberly studied at Purdue University from 1986 to 1990, where she completed her undergraduate education. She also attended Snider, furthering her academic qualifications. Her education has provided a foundation for her extensive career in the healthcare and diagnostics sectors.
Expertise in Sepsis Testing and Patient Safety
Kimberly possesses expertise in establishing new standards for sepsis testing accuracy, which is crucial for driving antibiotic stewardship and enhancing patient safety. She is part of a team that supports a product portfolio with over 70 issued patents and more than 50 additional patent applications pending, highlighting her involvement in innovative healthcare solutions.